We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Targeted Sequencing Approach for Sarcoma Gene Fusions Validated

By LabMedica International staff writers
Posted on 12 Sep 2018
Print article
Image: The Archer FusionPlex Sarcoma Kit: A targeted sequencing assay to simultaneously detect and identify fusions of 26 genes associated with soft tissue cancers (Photo courtesy of Illumina).
Image: The Archer FusionPlex Sarcoma Kit: A targeted sequencing assay to simultaneously detect and identify fusions of 26 genes associated with soft tissue cancers (Photo courtesy of Illumina).
Sarcomas are rare cancers that grow in a patient's connective tissue, such as bones, muscles, tendons, nerves, and fat. Symptoms may not be apparent, since the only signs of sarcomas are lumps on a person's skin.

It has been demonstrated that recurrent gene translocations are prevalent in these cancers. Although scientists currently use a variety of techniques to detect translocations, they often use fluorescence in situ hybridization (FISH) in routine diagnostic settings. Despite its proven uses, the tool's drawbacks include false-negative results when there are a high percentage of non-tumor cells, atypical FISH signals, and the dependency of probe availability.

Pathologists at the Leiden University Medical Center (Leiden, the Netherlands) collected 81 soft tissue or bone marrow samples, eight freshly frozen and 73 formalin-fixed, paraffin-embedded (FFPE), that either had a fusion-positive or unknown translocation status. To detect gene translocations, they isolated DNA and RNA from the tissue samples, and then prepared sequencing libraries of target-enriched complementary DNA (cDNA) using the FusionPlex Sarcoma kit (ArcherDX, Boulder, CO, USA).

The scientists used commercial FISH probes to detect translocations involving EWSR1, FUS, ALK, SS18, USP6, COL1A1 and PDGFB. In addition, the team used TaqMan probes to detect the most common fusion transcripts in Ewing and synovial sarcomas. The team performed immunohistochemistry for CAMTA1, TFE3, STAT6, ALK, ETV4, and CCNB3 mutations and then directly compared the AMP-based targeted outcomes to results from the secondary molecular techniques. A mixture of probes, primers, and cDNA were admixed with a qPCR Core kit.

The team reported that next-generation sequencing (NGS) yielded an average of 2.4 million read numbers per sample, with an average of 64% RNA reads. They found that 48 cases showed a fusion with AMP-based targeted NGS. In the remaining 33 cases, they did not find any gene fusion mutations. In addition, NGS results were in concord with FISH or RT-PCR in 29 of the cases. They included eight cases of Ewing sarcomas, with seven demonstrating an EWSRI-FLI1 fusion. In situations with discrepant results, the team pursued further analysis with additional FISH probes and RT-PCR primers. In seven samples, the team could not produce a specific immunohistochemical evaluation. However, they noted that these cases had histologic and immunohistochemical features that were characteristic for the tumors.

The team could not detect any specific fusion with ESWRI, despite demonstrating convincing ESWRI breakage with FISH probes. In contrast, the team found that both RT-PCR and FISH were easy to operate, inexpensive, and had high clinical accuracy. When using RT-PCR to make DNA, however, the team needed to ensure they had selected the correct translocation areas on the genome, as they might have to repeat the process if they identified the wrong fusion type.

Anne-Marie Cleton-Jansen, PhD, a study author and an associate pathology professor, said, “Regarding sarcomas and gene fusions, if a patient has a particular gene fusion, it's easier to perform a diagnosis. However, it must be done in the background of histology and patient specifics. One of the great things about using the FusionPlex Sarcoma kit is that you only need to know one of the translocation partners. You can then identify the second partner by next-generation sequencing.” The study was published on August 19, 2018, in The Journal of Molecular Diagnostics.

Related Links:
Leiden University Medical Center
ArcherDX


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.